blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4076464

EP4076464 - COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  23.09.2022
Database last updated on 03.08.2024
FormerThe international publication has been made
Status updated on  25.06.2021
Most recent event   Tooltip16.05.2024Supplementary search reportpublished on 12.06.2024  [2024/24]
Applicant(s)For all designated states
Orionis Biosciences, Inc.
950 Winter Street
Waltham, MA 02451 / US
[2022/43]
Inventor(s)01 / KLEY, Nikolai
c/o Orionis Biosciences, Inc. 950 Winter Street
Waltham, MA 02451 / US
02 / SABATINI, Riccardo
c/o Orionis Biosciences, Inc. 950 Winter Street
Waltham, MA 02451 / US
03 / SUH, Edward
c/o Orionis Biosciences, Inc. 950 Winter Street
Waltham, MA 02451 / US
 [2022/43]
Representative(s)Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[N/P]
Former [2022/43]Sagittarius IP
Marlow International
Parkway
Marlow, SL7 1YL / GB
Application number, filing date20901886.016.12.2020
[2022/43]
WO2020US65303
Priority number, dateUS201962949027P17.12.2019         Original published format: US 201962949027 P
[2022/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021126973
Date:24.06.2021
Language:EN
[2021/25]
Type: A1 Application with search report 
No.:EP4076464
Date:26.10.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 24.06.2021 takes the place of the publication of the European patent application.
[2022/43]
Search report(s)International search report - published on:US24.06.2021
(Supplementary) European search report - dispatched on:EP15.05.2024
ClassificationIPC:C07D211/88, C07D401/04, C07D401/12, C07D401/14, C07D471/04, C07D487/04, C07D491/048, C07D491/056, C07D495/04, A61K45/06, A61K31/506
[2024/12]
CPC:
C07D401/04 (EP,US); A61P35/00 (EP); A61P43/00 (US);
C07D211/40 (US); C07D211/88 (EP); C07D401/12 (EP);
C07D401/14 (EP,US); C07D405/14 (US); C07D417/04 (US);
C07D471/04 (EP,US); C07D487/04 (EP,US); C07D491/048 (EP,US);
C07D491/056 (EP,US); C07D495/04 (EP,US) (-)
Former IPC [2022/43]A61K31/506, A61K45/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/43]
TitleGerman:VERBINDUNGEN ZUR MODULATION VON PROTEINREKRUTIERUNG UND/ODER -ABBAU[2022/43]
English:COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION[2022/43]
French:COMPOSÉS MODULANT LE RECRUTEMENT ET/OU LA DÉGRADATION DE PROTÉINES[2022/43]
Entry into regional phase22.06.2022National basic fee paid 
22.06.2022Search fee paid 
22.06.2022Designation fee(s) paid 
22.06.2022Examination fee paid 
Examination procedure22.06.2022Examination requested  [2022/43]
24.01.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
29.12.2022Renewal fee patent year 03
28.12.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2010053732  (CELGENE CORP [US], et al);
 [I]WO2015038649  (SYNTA PHARMACEUTICALS CORP [US]);
 [I]WO2017059062  (US HEALTH [US], et al);
 [I]WO2017184995  (BIOVENTURES LLC [US]);
 [I]WO2018052945  (UNIV MICHIGAN REGENTS [US]);
 [X]WO2018071606  (ARVINAS INC [US]);
 [I]WO2018102725  (ARVINAS INC [US]);
 [I]WO2019078522  (KOREA RES INST CHEMICAL TECH [KR], et al);
International search[A]WO2017197051  (C4 THERAPEUTICS INC [US]);
 [A]CN107739389  (UNIV EAST CHINA NORMAL);
 [A]WO2018106870  (ICAHN SCHOOL MED MOUNT SINAI [US]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.